Prospective, randomized, double-blind trial to investigate the efficacy and safety of corneal cross-linking to halt the progression of keratoconus

BMC Ophthalmology

Volumn 15, Issue 1, 2015, Pages

  Lang, Stefan J ^a   Messmer, Elisabeth M ^b   Geerling, Gerd ^c,d   Mackert, Marc J ^b   Brunner, Tobias ^a   Dollak, Sylvia ^a   Kutchoukov, Borislav ^a,e   Böhringer, Daniel ^a   Reinhard, Thomas ^a   Maier, Philip ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; CROSS LINKING REAGENT; PHOTOSENSITIZING AGENT; RIBOFLAVIN;

ADOLESCENT; ADULT; CLINICAL TRIAL; CONTROLLED STUDY; CORNEA STROMA; DISEASE COURSE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; KERATOCONUS; KERATOMETRY; MALE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PHOTOCHEMOTHERAPY; PHYSIOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; ULTRAVIOLET RADIATION; VISUAL ACUITY;

ADOLESCENT; ADULT; COLLAGEN; CORNEAL STROMA; CORNEAL TOPOGRAPHY; CROSS-LINKING REAGENTS; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; KERATOCONUS; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROSPECTIVE STUDIES; RIBOFLAVIN; TREATMENT OUTCOME; ULTRAVIOLET RAYS; VISUAL ACUITY;

EID: 84937243022     PISSN: None     EISSN: 14712415     Source Type: Journal    
DOI: 10.1186/s12886-015-0070-7     Document Type: Article

References (42)

1. Krachmer JH, Feder RS, Belin MW. Keratoconus and related noninflammatory corneal thinning disorders. Surv Ophthalmol. 1984;28:293-322.
2. Tuft SJ, Hassan H, George S, Frazer DG, Willoughby CE, Liskova P. Keratoconus in 18 pairs of twins. Acta Ophthalmol (Copenh). 2012;90:e482-6.
3. Sugar J, Macsai MS. What causes keratoconus? Cornea. 2012;31:716-9.
4. Shapiro MB, France TD. The ocular features of Down's syndrome. Am J Ophthalmol. 1985;99:659-63.
5. Bawazeer A, Hodge W, Lorimer B. Atopy and keratoconus: a multivariate analysis. Br J Ophthalmol. 2000;84:834-6.
6. Rabinowitz YS. Keratoconus. Surv Ophthalmol. 1998;42:297-319.
7. Bühren J, Bischoff G, Kohnen T. Keratoconus: clinical aspects, diagnosis, therapeutic possibilities. Klin Monbl Augenheilkd. 2011;228:923-40. quiz 941-2.
8. McMahon TT, Edrington TB, Szczotka-Flynn L, Olafsson HE, Davis LJ, Schechtman KB. Longitudinal changes in corneal curvature in keratoconus. Cornea. 2006;25:296-305.
9. Spoerl E, Huhle M, Seiler T. Induction of cross-links in corneal tissue. Exp Eye Res. 1998;66:97-103.
10. Spoerl E, Wollensak G, Dittert D-D, Seiler T. Thermomechanical behavior of collagen-cross-linked porcine cornea. Ophthalmologica. 2004;218:136-40.
11. Wollensak G, Wilsch M, Spoerl E, Seiler T. Collagen fiber diameter in the rabbit cornea after collagen crosslinking by riboflavin/UVA. Cornea. 2004;23:503-7.
12. Hayes S, Boote C, Kamma-Lorger CS, Rajan MS, Harris J, Dooley E, et al. Riboflavin/UVA collagen cross-linking-induced changes in normal and keratoconus corneal stroma. PLoS One. 2011;6:e22405.
13. Spoerl E, Wollensak G, Seiler T. Increased resistance of crosslinked cornea against enzymatic digestion. Curr Eye Res. 2004;29:35-40.
14. Vetter JM, Tubic-Grozdanis M, Faust M, Lorenz K, Gericke A, Stoffelns BM. Effect of various compositions of riboflavin eye drops on the intraoperative corneal thickness during UVA-cross-linking in keratoconus eyes. Klin Monbl Augenheilkd. 2011;228:509-14.
15. Messmer EM, Meyer P, Herwig MC, Loeffler KU, Schirra F, Seitz B, et al. Morphological and immunohistochemical changes after corneal cross-linking. Cornea. 2013;32:111-7.
16. Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135:620-7.
17. Kampik D, Koch M, Kampik K, Geerling G. Corneal riboflavin/UV-A collagen cross-linking (CXL) in keratoconus: two-year results. Klin Monbl Augenheilkd. 2011;228:525-30.
18. Raiskup-Wolf F, Hoyer A, Spoerl E, Pillunat LE. Collagen crosslinking with riboflavin and ultraviolet-A light in keratoconus: long-term results. J Cataract Refract Surg. 2008;34:796-801.
19. Saffarian L, Khakshoor H, Zarei-Ghanavati M, Esmaily H. Corneal crosslinking for keratoconus in Iranian patients: Outcomes at 1 year following treatment. Middle East Afr J Ophthalmol. 2010;17:365-8.
20. Koller T, Pajic B, Vinciguerra P, Seiler T. Flattening of the cornea after collagen crosslinking for keratoconus. J Cataract Refract Surg. 2011;37:1488-92.
21. Asri D, Touboul D, Fournié P, Malet F, Garra C, Gallois A, et al. Corneal collagen crosslinking in progressive keratoconus: multicenter results from the French National Reference Center for Keratoconus. J Cataract Refract Surg. 2011;37:2137-43.
22. Derakhshan A, Shandiz JH, Ahadi M, Daneshvar R, Esmaily H. Short-term outcomes of collagen crosslinking for early keratoconus. J Ophthalmic Vis Res. 2011;6:155-9.
23. Viswanathan D, Males J. Prospective longitudinal study of corneal collagen crosslinking in progressive keratoconus. Clin Experiment Ophthalmol. 2013;41:531-6.
24. Wittig-Silva C, Whiting M, Lamoureux E, Lindsay RG, Sullivan LJ, Snibson GR. A randomized controlled trial of corneal collagen cross-linking in progressive keratoconus: preliminary results. J Refract Surg. 2008;24:S720-5.
25. Wittig-Silva C, Chan E, Islam FMA, Wu T, Whiting M, Snibson GR. A randomized, controlled trial of corneal collagen cross-linking in progressive keratoconus: Three-year results. Ophthalmology. 2014;121:812-21.
26. Hersh PS, Greenstein SA, Fry KL. Corneal collagen crosslinking for keratoconus and corneal ectasia: One-year results. J Cataract Refract Surg. 2011;37:149-60.
27. Greenstein SA, Fry KL, Hersh PS. Corneal topography indices after corneal collagen crosslinking for keratoconus and corneal ectasia: one-year results. J Cataract Refract Surg. 2011;37:1282-90.
28. O'Brart DPS, Chan E, Samaras K, Patel P, Shah SP. A randomised, prospective study to investigate the efficacy of riboflavin/ultraviolet A (370 nm) corneal collagen cross-linkage to halt the progression of keratoconus. Br J Ophthalmol. 2011;95:1519-24.
29. Sharma N, Suri K, Sehra SV, Titiyal JS, Sinha R, Tandon R, Vajpayee RB. Collagen cross-linking in keratoconus in Asian eyes: visual, refractive and confocal microscopy outcomes in a prospective randomized controlled trial. Int Ophthalmol. Feb 2015 [Epub ahead of print].
30. Pérez-Santonja JJ, Artola A, Javaloy J, Alió JL, Abad JL. Microbial keratitis after corneal collagen crosslinking. J Cataract Refract Surg. 2009;35:1138-40.
31. Eberwein P, Auw-Hädrich C, Birnbaum F, Maier PC, Reinhard T. Corneal melting after cross-linking and deep lamellar keratoplasty in a keratoconus patient. Klin Monbl Augenheilkd. 2008;225:96-8.
32. Greenstein SA, Fry KL, Bhatt J, Hersh PS. Natural history of corneal haze after collagen crosslinking for keratoconus and corneal ectasia: Scheimpflug and biomicroscopic analysis. J Cataract Refract Surg. 2010;36:2105-14.
33. Lange C, Böhringer D, Reinhard T. Corneal endothelial loss after crosslinking with riboflavin and ultraviolet-A. Graefes Arch Clin Exp Ophthalmol. 2012;250:1689-91.
34. Wollensak G, Hammer T, Herrmann CIA. Haze or calcific band keratopathy after crosslinking treatment? Ophthalmologe. 2008;105:864-5.
35. Koller T, Mrochen M, Seiler T. Complication and failure rates after corneal crosslinking. J Cataract Refract Surg. 2009;35:1358-62.
36. Maier P, Reinhard T. Riboflavin UVA cross-linking for keratoconus. Ophthalmologe. 2013;110:818-22.
37. Wagner H, Barr JT, Zadnik K. Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study: methods and findings to date. Cont Lens Anterior Eye. 2007;30:223-32.
38. Burns DM, Johnston FM, Frazer DG, Patterson C, Jackson AJ. Keratoconus: an analysis of corneal asymmetry. Br J Ophthalmol. 2004;88:1252-5.
39. Vianna LMM, Muñoz B, Hwang FS, Gupta A, Jun AS. Variability in Oculus Pentacam tomographer measurements in patients with keratoconus. Cornea. 2015;34:285-9.
40. Hashemi K, Guber I, Bergin C, Majo F. Reduced precision of the Pentacam HR in eyes with mild to moderate keratoconus. Ophthalmology. 2015;122:211-2.
41. Szalai E, Berta A, Hassan Z, Módis L. Reliability and repeatability of swept-source Fourier-domain optical coherence tomography and Scheimpflug imaging in keratoconus. J Cataract Refract Surg. 2012;38:485-94.
42. Gomes JAP, Tan D, Rapuano CJ, Belin MW, Ambrósio R, Guell JL, et al. Global consensus on keratoconus and ectatic diseases. Cornea. 2015;34:359-69.